ArticleFrontiers in pharmacology2024

Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19.

Yasmin Silva-Santos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.